DHI
48
4
AVY
53
3
DRI
53
5
HSIC
56
5
PGR
65
2
NWL
53
3
UA
50
-9
A
43
2
RSG
71
3
VTR
47
-7
DG
6
2
INTC
33
-2
IPG
56
3
SYK
64
-4
XYL
49
4
EFX
38
2
CAH
48
-5
NTAP
67
-3
HRB
57
5
DNB
82
4
DHI
48
4
AVY
53
3
DRI
53
5
HSIC
56
5
PGR
65
2
NWL
53
3
UA
50
-9
A
43
2
RSG
71
3
VTR
47
-7
DG
6
2
INTC
33
-2
IPG
56
3
SYK
64
-4
XYL
49
4
EFX
38
2
CAH
48
-5
NTAP
67
-3
HRB
57
5
DNB
82
4
Financhill
Back

Theriva Biologics 10K Form

Sell
44

TOVX
Theriva Biologics

Last Price:
1.29
Seasonality Move:
98.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.61M
Cash Flow: $-3.91M
Price / Cash Flow: 0
Annual Sales: $9.41
Price / Book: 0.14

Profitability

EPS (TTM): -33.18000
Net Income (TTM): $-26.69M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 12 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Sell
44
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $1.28. The Score for TOVX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.